NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

CompletedNA

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions: Alzheimer's Disease, Sleep Disturbance

Interventions: Active Lighting Intervention, Control Lighting Intervention

Countries: United States

Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morning light exposure; and 3) all day light exposure.

Eligibility overview

Sex: ALL

Age: 65 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosis of Alzheimer's disease or related dementia with a Montreal Cognitive Assessment score \<25
* Sleep disturbance with a Pittsburgh Sleep Quality Index score ≥5

Exclusion Criteria:

* Extensive brain vascular disease, traumatic brain injury, multiple sclerosis, Parkinson's Disease
* Obstructing cataracts
* Severe macular degeneration
* Use of sleep medication
* Use of oral melatonin
* untreated moderate to severe sleep apnea
* Severe restless leg syndrome
* Blindness

Locations (2)

Albany, New York, United States
New York, New York, United States